These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates. Stubenrauch K, Wessels U, Lenz H. J Pharm Biomed Anal; 2009 May 01; 49(4):1003-8. PubMed ID: 19250787 [Abstract] [Full Text] [Related]
10. A quantitative human monoclonal antibody immunoassay using anti-idiotypic antibody as a membrane antigen surrogate with surface-plasmon-resonance detection. Wong RB, Lee AH, Rangan VS, Cheng KC. Biotechnol Appl Biochem; 2009 May 01; 53(Pt 1):51-61. PubMed ID: 18680480 [Abstract] [Full Text] [Related]
11. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer. Reinartz S, Hombach A, Köhler S, Schlebusch H, Wallwiener D, Abken H, Wagner U. Cancer Res; 2003 Jun 15; 63(12):3234-40. PubMed ID: 12810653 [Abstract] [Full Text] [Related]
13. Isolation of human anti-idiotypic antibodies by phage display for clinical immune response assays. Tornetta M, Fisher D, O'Neil K, Geng D, Schantz A, Brigham-Burke M, Lombardo D, Fink D, Knight D, Sweet R, Tsui P. J Immunol Methods; 2007 Dec 01; 328(1-2):34-44. PubMed ID: 17888945 [Abstract] [Full Text] [Related]
14. Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor models. Chen Y, Clark S, Wong T, Chen Y, Chen Y, Dennis MS, Luis E, Zhong F, Bheddah S, Koeppen H, Gogineni A, Ross S, Polakis P, Mallet W. Cancer Res; 2007 May 15; 67(10):4924-32. PubMed ID: 17510422 [Abstract] [Full Text] [Related]
15. An Affinity Capture Elution (ACE) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drug. Bourdage JS, Cook CA, Farrington DL, Chain JS, Konrad RJ. J Immunol Methods; 2007 Oct 31; 327(1-2):10-7. PubMed ID: 17716682 [Abstract] [Full Text] [Related]
17. Identification and inhibition of drug target interference in immunogenicity assays. Zhong ZD, Dinnogen S, Hokom M, Ray C, Weinreich D, Swanson SJ, Chirmule N. J Immunol Methods; 2010 Apr 15; 355(1-2):21-8. PubMed ID: 20188106 [Abstract] [Full Text] [Related]
18. Strategies to estimate and improve drug tolerance in anti-drug antibody assays. Bütikofer L, Lemaillet G, Faust H. Bioanalysis; 2012 Aug 15; 4(16):1999-2012. PubMed ID: 22946916 [Abstract] [Full Text] [Related]
20. Detection of antidrug antibodies against human therapeutic antibodies lacking Fc-effector functions by usage of soluble Fcγ receptor I. Wessels U, Poehler A, Moheysen-Zadeh M, Zadak M, Staack RF, Umana P, Heinrich J, Stubenrauch K. Bioanalysis; 2016 Oct 15; 8(20):2135-45. PubMed ID: 27582032 [Abstract] [Full Text] [Related] Page: [Next] [New Search]